{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:52:11Z","timestamp":1783227131346,"version":"3.54.6"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":2624,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Wroclaw Medical University, Poland","award":["ST-905"],"award-info":[{"award-number":["ST-905"]}]},{"name":"Wroclaw Medical University, Poland","award":["ST-905"],"award-info":[{"award-number":["ST-905"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Despite attempts to improve the management of patients with acute heart failure (HF), virtually all therapeutic agents investigated in large clinical trials failed to show any consistent reduction in mortality and morbidity. Complexity of the clinical syndrome of acute HF seems to be likely an underlying explanation. Traditionally, clinical trials studied mixed patient populations with acute HF, and only recently, better clinical characterization of patients has been proposed. Dyspnoea is the most common presenting symptom related to hospital admission for acute HF. Whether in patients with acute HF, the pattern of symptoms onset preceding hospital admission is associated with clinical characteristics, and the outcomes have not yet been established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We investigated 137 patients (mean age: 65 \u00b1 13 years; 80% men) hospitalized due to acute HF with dyspnoea as major reported symptom, who were divided according to the time of its onset into those with acute (n = 98) vs. subacute (n = 39) onset (i.e. within 7 days vs. &amp;gt;7 days preceding hospital admission, respectively). On admission, the former group presented higher blood pressure (138 \u00b1 33 vs. 121 \u00b1 32 mmHg), more often moderate\u2013severe pulmonary congestion (33 vs. 8%), and lower bilirubin level [1.07 (0.72\u20131.60) vs. 1.27 (0.87\u20132.06); P &amp;lt; 0.05 in all comparisons]. There were no other differences in baseline clinical characteristics and laboratory indices. Higher percentage of patients with an acute dyspnoea onset reported marked\/moderate dyspnoea relief after 6 (18% vs. 7%), 24 (59% vs. 24%), and 48 h (80% vs. 46% assessed as an improvement of at least 5 points in self-reported 10-point Likert scale; P &amp;lt; 0.05 in all time points). In patients with an acute onset of dyspnoea after 48 h, a decrease of N-terminal pro BNP was more frequently observed (83% vs. 65%), and the levels of endothelin-1 were more reduced [\u22121.1 (\u22122.9\u20130.03) vs 0.4 (\u22122.2\u20131.4); all P &amp;lt; 0.05]. Patients with acute onset experienced less in-hospital HF worsening (13% vs. 40%, P = 0.001), and 1 year cardiovascular mortality was significantly lower (20% vs. 41%, P = 0.01). On the multivariable analysis, subacute pattern of dyspnoea was independent predictor of 12 month cardiovascular mortality in patients with acute HF after adjusting for other prognostic factors: systolic blood pressure, urea, and HF de novo [hazard ratio (95% confidence interval): 2.32 (1.13\u20134.75), P = 0.02].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with acute HF, the pattern of symptoms onset is associated with baseline differences in clinical characteristics, biomarker profile, response to standard treatment, and the long-term outcomes. This is relevant information for planning future clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12371","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:11:55Z","timestamp":1542154315000},"page":"16-26","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Patterns of Dyspnoea Onset in Patients with Acute Heart Failure: Clinical and Prognostic Implications"],"prefix":"10.1093","volume":"6","author":[{"given":"Justyna Maria","family":"Sokolska","sequence":"first","affiliation":[{"name":"Department of Heart Diseases, Wroclaw Medical University , Wroclaw ,","place":["Poland"]},{"name":"Department of Cardiology, Military Hospital, Centre for Heart Diseases , Wroclaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Sokolski","sequence":"additional","affiliation":[{"name":"Department of Heart Diseases, Wroclaw Medical University , Wroclaw ,","place":["Poland"]},{"name":"Department of Cardiology, Military Hospital, Centre for Heart Diseases , Wroclaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zymli\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Heart Diseases, Wroclaw Medical University , Wroclaw ,","place":["Poland"]},{"name":"Department of Cardiology, Military Hospital, Centre for Heart Diseases , Wroclaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Biegus","sequence":"additional","affiliation":[{"name":"Department of Heart Diseases, Wroclaw Medical University , Wroclaw ,","place":["Poland"]},{"name":"Department of Cardiology, Military Hospital, Centre for Heart Diseases , Wroclaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Siwo\u0142owski","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Military Hospital, Centre for Heart Diseases , Wroclaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Nawrocka-Millward","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Military Hospital, Centre for Heart Diseases , Wroclaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa Anita","family":"Jankowska","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Military Hospital, Centre for Heart Diseases , Wroclaw ,","place":["Poland"]},{"name":"Laboratory for Applied Research on Cardiovascular System, Department of Heart Diseases, Wroclaw Medical University , Wroclaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Todd","sequence":"additional","affiliation":[{"name":"Singulex, California Inc. , Alameda, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Banasiak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Military Hospital, Centre for Heart Diseases , Wroclaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"name":"Department of Heart Diseases, Wroclaw Medical University , Wroclaw ,","place":["Poland"]},{"name":"Department of Cardiology, Military Hospital, Centre for Heart Diseases , Wroclaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"2026012115102042500_ehf212371-bib-0001","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Journal of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012115102042500_ehf212371-bib-0002","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11897-014-0220-x","article-title":"Understanding the epidemic of heart failure: past, present, and future","volume":"11","author":"Dunlay","year":"2014","journal-title":"Curr Heart Fail Rep"},{"key":"2026012115102042500_ehf212371-bib-0003","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3390\/ijerph7041807","article-title":"The heart failure epidemic","volume":"7","author":"Roger","year":"2010","journal-title":"Int J Environ Res Public Health"},{"key":"2026012115102042500_ehf212371-bib-0004","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ahj.2010.07.020","article-title":"Generalizability and longitudinal outcomes of a national heart failure clinical registry: comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries","volume":"160","author":"Kociol","year":"2010","journal-title":"Am Heart J"},{"key":"2026012115102042500_ehf212371-bib-0005","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/ejhf.319","article-title":"Heart failure as a general pandemic in Asia","volume":"17","author":"Shimokawa","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0006","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/heartjnl-2017-311813","article-title":"Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction","volume":"104","author":"Choi","year":"2018","journal-title":"Heart"},{"key":"2026012115102042500_ehf212371-bib-0007","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"2026012115102042500_ehf212371-bib-0008","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijcard.2012.09.128","article-title":"Long-term survival after hospitalization for acute heart failure\u2014Differences in prognosis of acutely decompensated chronic and new-onset acute heart failure","volume":"168","author":"Lassus","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026012115102042500_ehf212371-bib-0009","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJMoa1601895","article-title":"Effect of ularitide on cardiovascular mortality in acute heart failure","volume":"376","author":"Packer","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012115102042500_ehf212371-bib-0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/17512433.2017.1299574","article-title":"Current and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure","volume":"10","author":"Krzysztofik","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2026012115102042500_ehf212371-bib-0011","volume-title":"RELAX-AHF-2: serelaxin in acute heart failure, part 1","author":"JR. T","year":"2017"},{"key":"2026012115102042500_ehf212371-bib-0012","volume-title":"RELAX-AHF-2: serelaxin in acute heart failure, part 2","author":"Metra","year":"2017"},{"key":"2026012115102042500_ehf212371-bib-0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2016.11.124","article-title":"Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes","volume":"233","author":"Tamargo","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026012115102042500_ehf212371-bib-0014","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(03)00309-7","article-title":"Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure","volume":"41","author":"Nohria","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026012115102042500_ehf212371-bib-0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2010.05.020","article-title":"A review of dyspnea in acute heart failure syndromes","volume":"160","author":"West","journal-title":"Am Heart J"},{"key":"2026012115102042500_ehf212371-bib-0016","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.amjcard.2014.09.048","article-title":"Relation of dyspnea severity on admission for acute heart failure with outcomes and costs","volume":"115","author":"Mentz","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026012115102042500_ehf212371-bib-0017","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ijcard.2017.01.012","article-title":"Elevated troponin I level assessed by a new high-sensitive assay and the risk of poor outcomes in patients with acute heart failure","volume":"230","author":"Zymli\u0144ski","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026012115102042500_ehf212371-bib-0018","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"2026012115102042500_ehf212371-bib-0019","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0020","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ncpneph0627","article-title":"Comparing the Cockcroft\u2013Gault and MDRD equations for calculation of GFR and drug doses in the elderly","volume":"3","author":"Berman","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"2026012115102042500_ehf212371-bib-0021","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1373\/clinchem.2008.107391","article-title":"Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice","volume":"55","author":"Wu","year":"2009","journal-title":"Clin Chem"},{"key":"2026012115102042500_ehf212371-bib-0022","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"2026012115102042500_ehf212371-bib-0023","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ejhf.809","article-title":"New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment","volume":"19","author":"Cowie","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0024","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ejhf.516","article-title":"Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency","volume":"18","author":"Anker","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ejhf.682","article-title":"Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry","volume":"19","author":"Arrigo","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0026","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.872","article-title":"Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"19","author":"Harjola","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0027","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ejhf.890","article-title":"Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0028","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ejhf.566","article-title":"European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions","volume":"18","author":"Crespo-Leiro","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0029","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/CIRCHEARTFAILURE.112.970335","article-title":"Hemodynamic determinants of dyspnea improvement in acute decompensated heart failureclinical perspective","volume":"6","author":"Solomonica","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2010.05.020","article-title":"A review of dyspnea in acute heart failure syndromes","volume":"160","author":"West","year":"2010","journal-title":"Am Heart J"},{"key":"2026012115102042500_ehf212371-bib-0031","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/eurheartj\/ehr042","article-title":"Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study","volume":"32","author":"Metra","year":"2011","journal-title":"Eur Heart J"},{"key":"2026012115102042500_ehf212371-bib-0032","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCHEARTFAILURE.111.961581","article-title":"Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the protect pilot study","volume":"4","author":"O'Connor","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0033","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/eurjhf\/hfq021","article-title":"Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study","volume":"12","author":"Metra","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0034","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/eurjhf\/hfq132","article-title":"Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study","volume":"12","author":"Metra","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0035","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.jacc.2008.12.079","article-title":"End points for clinical trials in acute heart failure syndromes","volume":"53","author":"Allen","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026012115102042500_ehf212371-bib-0036","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/eurjhf\/hfs188","article-title":"Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF","volume":"15","author":"Mentz","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0037","volume-title":"Efficacy, safety and tolerability of serelaxin when added to standard therapy in AHF\u2013full text view\u2013Clinicaltrials.gov"},{"key":"2026012115102042500_ehf212371-bib-0038","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ahj.2015.04.007","article-title":"Worsening heart failure during hospitalization for acute heart failure: insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF)","volume":"170","author":"Kelly","year":"2015","journal-title":"Am Heart J"},{"key":"2026012115102042500_ehf212371-bib-0039","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijcard.2016.10.002","article-title":"In-hospital worsening heart failure in patients admitted for acute heart failure","volume":"225","author":"Carubelli","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012115102042500_ehf212371-bib-0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003048","article-title":"Implications of using different definitions on outcomes in worsening heart failure","volume":"9","author":"Kelly","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0041","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001088","article-title":"In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization","volume":"3","author":"DeVore","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2026012115102042500_ehf212371-bib-0042","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/ejhf.515","article-title":"Worsening heart failure in \u2018real-world\u2019 clinical practice: predictors and prognostic impact","volume":"19","author":"AlFaleh","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0043","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/ejhf.333","article-title":"In-hospital worsening heart failure","volume":"17","author":"Butler","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0044","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ejhf.456","article-title":"Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy","volume":"18","author":"Perez","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115102042500_ehf212371-bib-0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"2026012115102042500_ehf212371-bib-0046","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/eurheartj\/ehu484","article-title":"Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies","volume":"36","author":"Anker","year":"2015","journal-title":"Eur Heart J"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12371","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/1\/16\/66135874\/eschf_6_1_16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/1\/16\/66135874\/eschf_6_1_16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:13:27Z","timestamp":1769026407000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/6\/1\/16\/8403635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,11,13]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12371","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734446227.793556980","asserted-by":"object"}]},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,11,13]]},"assertion":[{"value":"2018-02-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}